Delivery Order SPE2DB22D2206-SPE2DB25FFL80
Award Date
2/5/25
Potential Completion Date
2/27/25
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $33,173.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Tecentriq, a cancer immunotherapy medication, with a completion date of January 2, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $8,016.30, is for the delivery of 840 mg/14 ml vials of the cancer medication Tecentriq (atezolizumab). It is a firm-fixed-price delivery order contract with a completion date of December 10, 2024. The award is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an award ceiling value of $8,504.62 and a period of performance through February 13, 2025. The contract is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $16,032.60 Firm Fixed Price Delivery Order contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $86,205.24 and covers the delivery of Tecentriq 840 mg/14 ml vials. The contract was awarded on September 16, 2021, with an ultimate completion date of October 7, 2021. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is the prime...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 840 mg/14 ml vials of the pharmaceutical product Tecentriq, with a potential value of $4,008.15 and a completion date of March 20, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide this medication to support military treatment programs and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, which has a firm fixed price of $35,736.42, is a delivery order with an ultimate completion date of September 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.87 firm fixed-price delivery order contract is for the supply of TECVAYLI 30 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,912.14 firm fixed-price delivery order is for the drug TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a period of performance through December 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,283.74 firm fixed-price delivery order is for the supply of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...